Daily FNArena News

A wrap of the day’s activity on the Australian stock market.

Cochlear may be at the top of its market but, after a lukewarm half year, brokers see some potential for the leader to be challenged.

With reporting season for Australian insurance companies approaching, analysts discuss whether or not (or perhaps weather or not) the recent positive run can be maintained.

Microcap specialist Microequities explains why it remains at arm’s length from software company Corum Ltd.

China is at an important crossroads in its economic development, but choosing the right course requires some significant change according to one leading economist.

FNArena’s weekly update on short positions in the Australian share market.

A wrap of the day’s activity on the Australian stock market.

Earnings outlook is mixed but generally positive and there’s plenty of catalysts for gaming this year, according to brokers.

It’s a gloomy view for improving profit margins in the latest Dunn & Bradstreet survey, as Australian business hunkers down for a soft June quarter.

As 2012 drew to a close uranium buffs had a few things to cheer about and after a rough ride in January, the direction remains positive.